HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,932 | -19.6% | 699,553 | -28.6% | 0.05% | -21.9% |
| Q2 2023 | $100,710 | -41.7% | 979,194 | -38.1% | 0.06% | -19.0% |
| Q1 2023 | $172,711 | +26.3% | 1,582,444 | +31.7% | 0.08% | +27.4% |
| Q4 2022 | $136,723 | -99.9% | 1,201,449 | -68.8% | 0.06% | -76.2% |
| Q3 2022 | $238,420,000 | +936.4% | 3,852,296 | +1235.5% | 0.26% | +1757.1% |
| Q2 2022 | $23,005,000 | -62.1% | 288,445 | -49.9% | 0.01% | -70.2% |
| Q1 2022 | $60,620,000 | +79.2% | 576,173 | +83.6% | 0.05% | +683.3% |
| Q4 2021 | $33,820,000 | +60.6% | 313,816 | +63.2% | 0.01% | -33.3% |
| Q3 2021 | $21,061,000 | +7.6% | 192,271 | -8.1% | 0.01% | 0.0% |
| Q2 2021 | $19,582,000 | +26.8% | 209,122 | +24.6% | 0.01% | +12.5% |
| Q1 2021 | $15,445,000 | +120.6% | 167,813 | +75.3% | 0.01% | +100.0% |
| Q4 2020 | $7,001,000 | +1148.0% | 95,718 | +1225.2% | 0.00% | – |
| Q3 2020 | $561,000 | -5.6% | 7,223 | -32.3% | 0.00% | – |
| Q2 2020 | $594,000 | +33.5% | 10,677 | -29.0% | 0.00% | – |
| Q1 2020 | $445,000 | -82.6% | 15,040 | -78.7% | 0.00% | -100.0% |
| Q4 2019 | $2,551,000 | -54.2% | 70,459 | -65.6% | 0.00% | -33.3% |
| Q3 2019 | $5,573,000 | -46.3% | 204,648 | -52.6% | 0.00% | -50.0% |
| Q2 2019 | $10,380,000 | – | 431,357 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |